Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Braunschweiger

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|April 6, 2004
Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptidesBettina Langhans, Ingrid Braunschweiger, Susann Schweitzer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 1, 2005
Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptidesBettina Langhans, Susann Schweitzer, Ingrid Braunschweiger, et al.
The Journal of Infectious Diseases|January 15, 2004
Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitroBettina Langhans, Susann Schweitzer, Hans Dieter Nischalke, et al.
Vaccine|March 1, 2006
Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2Bettina Langhans, Ingrid Braunschweiger, Hans-Dieter Nischalke, et al.
Plos One|August 1, 2012
Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis CBettina Langhans, Hans Dieter Nischalke, Simone Arndt, et al.
Journal of Hepatology|December 15, 2010
Interferon-lambda serum levels in hepatitis CBettina Langhans, Bernd Kupfer, Ingrid Braunschweiger, et al.
Clinical Science (London, England : 1979)|March 13, 2010
Core-specific adaptive regulatory T-cells in different outcomes of hepatitis CBettina Langhans, Ingrid Braunschweiger, Simone Arndt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|April 6, 2004
Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptidesBettina Langhans, Ingrid Braunschweiger, Susann Schweitzer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 1, 2005
Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptidesBettina Langhans, Susann Schweitzer, Ingrid Braunschweiger, et al.
The Journal of Infectious Diseases|January 15, 2004
Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitroBettina Langhans, Susann Schweitzer, Hans Dieter Nischalke, et al.
Vaccine|March 1, 2006
Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2Bettina Langhans, Ingrid Braunschweiger, Hans-Dieter Nischalke, et al.
Plos One|August 1, 2012
Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis CBettina Langhans, Hans Dieter Nischalke, Simone Arndt, et al.
Journal of Hepatology|December 15, 2010
Interferon-lambda serum levels in hepatitis CBettina Langhans, Bernd Kupfer, Ingrid Braunschweiger, et al.
Clinical Science (London, England : 1979)|March 13, 2010
Core-specific adaptive regulatory T-cells in different outcomes of hepatitis CBettina Langhans, Ingrid Braunschweiger, Simone Arndt, et al.
Pageof 1